Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines

被引:1
|
作者
Minemura, M
Tanimura, H
Tabor, E
机构
[1] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[2] Oita Med Sch, Dept Surg 2, Oita, Japan
关键词
multidrug resistance; hepatocellular carcinoma; hepatoblastoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpression of either of the multidrug resistance genes MDR1 and MRP is associated with resistance of tumors to multiple chemotherapeutic agents. Overexpression of MDR1 has been reported in some cell lines derived from human hepatocellular carcinomas (HCC) and hepatoblastomas (HB). The human gene for cMOAT ('canalicular multispecific organic anion transporter'), a homologue of MRP, is thought to mediate hepatobiliary excretion of organic anions and to be associated with cisplatin resistance. In this study, expression levels of MDR1 and cMOAT were examined in 9 human HCC and HE cell lines and 10 other human cancer cell lines. Overexpression of the cMOAT gene was observed in all 9 HCC and HE cell lines and 3 of 10 other cancer cell lines. Co-overexpression of the cMOAT and MDR1 genes was observed in 7 of 9 HCC and HE cell lines, but in none of the 10 other cancer cell lines. Seven of the HCC and HE cell lines that had overexpression of the cMOAT gene were shown to be highly resistant to cisplatin compared to 2 HCC cell lines with low levels of cMOAT expression. These findings suggest that overexpression of cMOAT could contribute to cisplatin resistance in HCC and HB.
引用
收藏
页码:559 / 563
页数:5
相关论文
共 50 条
  • [1] Overexpression of drug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines.
    Minemura, M
    Tanimura, H
    Tabor, E
    HEPATOLOGY, 1997, 26 (04) : 181 - 181
  • [2] Overexpression of the multidrug resistance genes MDR1 and MDR2 in hepatocellular carcinomas
    Oswald, M
    Grutzner, U
    Beuers, U
    Paumgartner, G
    KullakUblick, GA
    HEPATOLOGY, 1996, 24 (04) : 278 - 278
  • [3] HUMAN HEPATOCELLULAR-CARCINOMA CELL-LINES EXHIBIT MULTIDRUG RESISTANCE UNRELATED TO MDR1 GENE-EXPRESSION
    SHEN, DW
    LU, YG
    CHIN, KV
    PASTAN, I
    GOTTESMAN, MM
    JOURNAL OF CELL SCIENCE, 1991, 98 : 317 - 322
  • [4] Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma
    Wang, Zhi-Chao
    Liu, Long-Zi
    Liu, Xin-Yang
    Hu, Jin-Jing
    Wu, Yong-Na
    Shi, Jie-Yi
    Yang, Liu-Xiao
    Duan, Meng
    Wang, Xiao-Ying
    Zhou, Jian
    Fan, Jia
    Gao, Qiang
    TUMOR BIOLOGY, 2015, 36 (09) : 7007 - 7015
  • [5] The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma -: Clinical course and in vivo model
    Warmann, S
    Hunger, M
    Teichmann, B
    Flemming, P
    Gratz, KF
    Fuchs, J
    CANCER, 2002, 95 (08) : 1795 - 1801
  • [6] EXPRESSION OF MULTIDRUG RESISTANCE GENES (MDR1) IN RHEUMATOID SYNOVIUM
    JORGENSEN, C
    ROSSI, JF
    BERNARD, JC
    CANOVAS, JF
    SIMONYLAFONTAINE, J
    RADAI, M
    REME, T
    SANY, J
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S201 - S201
  • [7] OVEREXPRESSION OF THE MDR1 GENE AND P-GLYCOPROTEIN IN HUMAN HEPATOCELLULAR-CARCINOMA
    HUANG, CC
    WU, MC
    XU, GW
    LI, DZ
    CHENG, H
    TU, ZX
    JIANG, HQ
    GU, JR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) : 262 - 264
  • [8] The role of multidrug resistance gene 1 (MDR1) in breast carcinoma resistance
    Vaclavikova, R.
    Alnaes, G.
    Hubackova, M.
    Kubala, E.
    Kodet, R.
    Mrhalova, M.
    Novotny, J.
    Gut, I.
    Kristensen, V. N.
    Soucek, P.
    FEBS JOURNAL, 2007, 274 : 119 - 119
  • [9] Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer
    Campling, BG
    Young, LC
    Baer, KA
    Lam, YM
    Deeley, RG
    Cole, SPC
    Gerlach, JH
    CLINICAL CANCER RESEARCH, 1997, 3 (01) : 115 - 122
  • [10] MDR1, A MULTIDRUG RESISTANCE GENE
    CALVO, F
    DECREMOUX, P
    BULLETIN DU CANCER, 1989, 76 (09) : 973 - 977